CH BIOTECH SER (08037) Subsidiary Secures Loan Facility of Up to RMB 180 Million

Stock News

2025/09/11

CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an indirect wholly-owned subsidiary of the Company as of the announcement date, entered into a loan agreement with Qionghai Branch of Hainan Rural Commercial Bank Co., Ltd. as the lender, acting as the borrower.

Under the agreement, the lender has agreed to provide Pengbo Hainan with a loan facility of up to RMB 180 million in principal amount. The loan will provide additional support for the construction of the Boron Neutron Capture Therapy center, with the goal of opening and commencing operations by the end of 2025 to provide boron neutron therapy services to cancer patients in need.

Leveraging the supportive policies of the Boao Lecheng pilot zone and using this center as a demonstration project, the Group is committed to developing a network of Boron Neutron Capture Therapy centers covering China in the future, developing franchise hospitals to generate additional revenue streams.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1120506638"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120506638\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120506638?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-11 12:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120506638","market":"us","top_or_hot":-1,"title":"CH BIOTECH SER (08037) Subsidiary Secures Loan Facility of Up to RMB 180 Million","media":"Stock News","content":"<p>CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an indirect wholly-owned subsidiary of the Company as of the announcement date, entered into a loan agreement with Qionghai Branch of Hainan Rural Commercial Bank Co., Ltd. as the lender, acting as the borrower.</p>\n<p>Under the agreement, the lender has agreed to provide Pengbo Hainan with a loan facility of up to RMB 180 million in principal amount. The loan will provide additional support for the construction of the Boron Neutron Capture Therapy center, with the goal of opening and commencing operations by the end of 2025 to provide boron neutron therapy services to cancer patients in need.</p>\n<p>Leveraging the supportive policies of the Boao Lecheng pilot zone and using this center as a demonstration project, the Group is committed to developing a network of Boron Neutron Capture Therapy centers covering China in the future, developing franchise hospitals to generate additional revenue streams.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CH BIOTECH SER (08037) Subsidiary Secures Loan Facility of Up to RMB 180 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCH BIOTECH SER (08037) Subsidiary Secures Loan Facility of Up to RMB 180 Million\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-09-11 12:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an indirect wholly-owned subsidiary of the Company as of the announcement date, entered into a loan agreement with Qionghai Branch of Hainan Rural Commercial Bank Co., Ltd. as the lender, acting as the borrower.</p>\n<p>Under the agreement, the lender has agreed to provide Pengbo Hainan with a loan facility of up to RMB 180 million in principal amount. The loan will provide additional support for the construction of the Boron Neutron Capture Therapy center, with the goal of opening and commencing operations by the end of 2025 to provide boron neutron therapy services to cancer patients in need.</p>\n<p>Leveraging the supportive policies of the Boao Lecheng pilot zone and using this center as a demonstration project, the Group is committed to developing a network of Boron Neutron Capture Therapy centers covering China in the future, developing franchise hospitals to generate additional revenue streams.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1219","symbol_name":"保健護理服務","start_time":0,"source_url":"","article_id":"1120506638","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120506638","pubTimestamp":1757565257,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1219":"保健护理服务","BK1511":"疑似财技股","08037":"中国生物科技服务"},"translate_title":"CH BIOTECH SER(08037)附属公司取得最高人民币1.8亿元贷款融资","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"CH BIOTECH SER (08037) announced that on September 9, 2025, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo Hainan), a limited liability company incorporated in China and an indirect wholly-owned subsidiary of the Company as of the announcement date, entered into a loan agreement with Qionghai Branch of Hainan Rural Commercial Bank Co., Ltd. as the lender, acting as the borrower.\nUnder the agreement, the lender has agreed to provide Pengbo Hainan with a loan facility of up to RMB 180 million in principal amount. The loan will provide additional support for the construction of the Boron Neutron Capture Therapy center, with the goal of opening and commencing operations by the end of 2025 to provide boron neutron therapy services to cancer patients in need.\nLeveraging the supportive policies of the Boao Lecheng pilot zone and using this center as a demonstration project, the Group is committed to developing a network of Boron Neutron Capture Therapy centers covering China in the future, developing franchise hospitals to generate additional revenue streams.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}